Exclusive Brand Protection and Anti-Counterfeiting Content
Is your brand protection strategy compliant with the EU regulations in 2019?
As the EU FMD has recently come into full force, we wanted to understand what it would mean for serialisation managers and industry professionals, and how it will affect a pharmaceutical company's brand protection strategy.
In our exclusive interview with Ifigenia Dimitriadou, Manager Serialisation Operations and Logistics at Celgene, she shares her insights on what is happening post-FMD and what are realistic timelines for its implementation. Other topics include:
- What serialisation managers should focus on now that serialisation is in place
- How companies are using data to drive their anti-counterfeiting and brand protection strategy
- How serialisation roles are evolving into anti-counterfeiting and brand protection roles
- How a company should build its anti-counterfeiting and brand protection strategy – and where serialisation fits into this picture
- Plus much more.
Fill in your details to download the full interview.
Click on 'download' to see who is attending the Pharmaceutical Anti-Counterfeiting Forum 2019.